Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Heidelberg Pharma AG (XETRA: HPHA)

 
HPHA Technical Analysis
5
As on 21st Aug 2025 HPHA STOCK Price closed @ 4.32 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 2.63 & Strong Buy for SHORT-TERM with Stoploss of 3.01 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

HPHASTOCK Price

Open 4.34 Change Price %
High 4.34 1 Day 0.07 1.65
Low 4.20 1 Week 0.09 2.13
Close 4.32 1 Month -0.45 -9.43
Volume 7480 1 Year 1.26 41.18
52 Week High 4.77 | 52 Week Low 2.17
 
XETRA Germany Most Active Stocks
LHAR 2.05 -20.23%
BBVA 5.00 -2.72%
BBVA 5.00 -2.72%
BBVA 5.00 -2.72%
BVBA 0.02 -60.00%
SNH 0.16 6.67%
SNH 0.16 6.67%
SNH 0.16 6.67%
AMMN 8500.00 1440578.00%
PHIA 31.36 1.92%
 
XETRA Germany Top Gainers Stocks
AMMN 8500.00 1440578.00%
PDA 2.73 196.74%
PDA 2.73 196.74%
PDA 2.73 196.74%
PDA 2.73 196.74%
PDA 2.73 196.74%
PDA 2.73 196.74%
PAG 0.02 100.00%
PAG 0.02 100.00%
PAG 0.02 100.00%
 
XETRA Germany Top Losers Stocks
F03 0.56 -99.14%
F03 0.56 -99.14%
F03 0.56 -99.14%
F03 0.56 -99.14%
IQL 0.02 -66.67%
IQL 0.02 -66.67%
EIN3 60.20 -63.95%
EIN3 60.20 -63.95%
EIN3 60.20 -63.95%
LEO 0.04 -63.64%
 
 
HPHA
Daily Charts		 HPHA
Intraday Charts		 Whats New @
Bazaartrend		 HPHA
Free Analysis
 
HPHA Important Levels Intraday
RESISTANCE4.59
RESISTANCE4.50
RESISTANCE4.45
RESISTANCE4.40
SUPPORT4.24
SUPPORT4.19
SUPPORT4.14
SUPPORT4.05
 
HPHA Forecast August 2025
Share
4th UP Forecast4.84
3rd UP Forecast4.67
2nd UP Forecast4.57
1st UP Forecast4.47
1st DOWN Forecast4.17
2nd DOWN Forecast4.07
3rd DOWN Forecast3.97
4th DOWN Forecast3.8
 
HPHA Weekly Forecast
4th UP Forecast5.05
3rd UP Forecast4.82
2nd UP Forecast4.67
1st UP Forecast4.53
1st DOWN Forecast4.11
2nd DOWN Forecast3.97
3rd DOWN Forecast3.82
4th DOWN Forecast3.59
 
HPHA Forecast2025
4th UP Forecast10.58
3rd UP Forecast8.57
2nd UP Forecast7.33
1st UP Forecast6.09
1st DOWN Forecast2.55
2nd DOWN Forecast1.31
3rd DOWN Forecast0.07
4th DOWN Forecast-1.94
 
 
HPHA Other Details
Segment EQ
Market Capital 188293232.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
HPHA Address
HPHA
 
HPHA Latest News
 
Your Comments and Response on Heidelberg Pharma AG
 
HPHA Business Profile
Heidelberg Pharma AG, a biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, other European countries, the United States, and internationally. It is developing HDP-101 for the treatment of multiple myeloma; HDP-102 for the treatment of non-Hodgkin lymphoma; HDP-103, an ATAC candidate to treat prostate cancer; and CDXX-ATACs, a candidate for the treatment of solid/hematological tumors. The company is also developing MGTA-ATACs for HSCs, conditioning programs for blood cancers, and genetic diseases; TAK-ATACs for oncology treatment; and EMR-ATAC for the treatment of solid tumors. In addition, it provides preclinical research services in the fields of cancer, and inflammatory and autoimmune diseases. The company was formerly known as Wilex AG and changed its name to Heidelberg Pharma AG in October 2017. Heidelberg Pharma AG was founded in 1997 and is based in Ladenburg, Germany. Address: Gregor-Mendel-Strasse 22, Ladenburg, Germany, 68526
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service